Japanese firms strike screening deals under neglected diseases initiative
This article was originally published in Scrip
Executive Summary
Several Japanese pharmaceutical firms involved in the new Global Health Innovative Technology (GHIT) Fund public-private partnership in Japan have made their first commitments to help search for drugs for major neglected diseases.